Skip to content

Pulmonary Disease in a Psychiatric Inpatient Population

Pulmonary Disease in a Psychiatric Inpatient Population, a Screening Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01823627
Enrollment
46
Registered
2013-04-04
Start date
2013-03-31
Completion date
2013-07-31
Last updated
2018-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Airway Disease

Keywords

COPD, Psychiatric inpatient, Smoking

Brief summary

Purpose: Patients with mental health disorders have a reduced life expectancy, compared to the general population. The shorter life expectancy is caused by natural and unnatural death. In general, patients with a mental disorder tend to have a more unhealthy lifestyle, than the general population, characterized by e.g. lack of exercise and smoking. Hypothesis Chronic obstructive pulmonary disease (COPD) is underdiagnosed in psychiatric inpatients There is a higher prevalence of COPD in psychiatric inpatients compared to the general population Screening of patients with one respiratory symptom and a smoking history, has the same sensitivity regarding to diagnosis of COPD, as screening all patients with a smoking history Method: 80 psychiatric inpatients will undergo spirometry with reversibility test and COPD Assessment Test (CATest). Furthermore, patient history regarding respiratory symptoms and smoking will be taken into account.

Interventions

Spirometry with reversibility test and CATest questionaire. following will be measured FEV1 L/s FVC L/s FEV1/FVC ration

Sponsors

Naestved Hospital
CollaboratorOTHER
Psykiatrien Syd
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Inpatients in Psykiatrien Syd, Region Zealand, ward S1,S2,S3,S4,S5,S6 * Admission time over 48 hours

Exclusion criteria

* Patients who is not able to perform spirometry due to their psychiatric condition

Design outcomes

Primary

MeasureTime frameDescription
Tiffeneau indexat enrollment\- FEV1/FVC ratio

Secondary

MeasureTime frameDescription
forced vital capacityat enrollmentFVC L/s
Forced expiratory volume in 1 secondat enrollmentFEV1 L

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026